Download PDF
Zentralbl Chir 2002; 127(5): 453-455
DOI: 10.1055/s-2002-31977
Originalarbeiten und Übersichten

© Georg Thieme Verlag Stuttgart · New York

Die thorakoskopische videoassistierte Talkumpleurodese - eine effektive Behandlungsmethode des malignen Pleuraergusses

Thoracoscopic Video-Assisted Talcum Pleurodesis (TTP) - Effective Treatment of Malignant Pleural EffusionG. Brünagel, P. Decker, St. Manekeller, A. Hirner
  • Klinik und Poliklinik für Allgemein-, Viszeral-, Thorax- und Gefäßchirurgie der Rheinischen Friedrich-Wilhelms-Universität Bonn
Further Information

Publication History

Publication Date:
29 April 2004 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Einleitung: Das palliative Therapieziel eines malignen Pleuraergusses sollte eine schnelle, effektive und schmerzlose Beseitigung des Ergusses sein.
Patienten und Methode: Seit 1995 wurden bei 46 Patienten retrospektiv die Ergebnisse von 51 videoassistierten thorakoskopischen Talkumpleurodesen (TTP) analysiert. Häufigste Genese der malignen Pleuraergüsse waren das Mammakarzinom, gefolgt von dem Bronchialkarzinom. Voraussetzung zur videoassistierten TTP war die Verifizierung des malignen Pleuraergusses mittels einer Zytologie.
Ergebnisse: An Komplikationen sahen wir eine Pneumonie und 2 Rezidive. Vier Patienten starben postoperativ aufgrund ihrer fortgeschrittenen Grunderkrankung. Die durchschnittliche Liegezeit betrug 8 (3-55) Tage.
Schlussfolgerung: Die videoassistierte TTP stellt zur palliativen Behandlung maligner Pleuraergüsse das therapeutische Verfahren der Wahl dar, da die Rezidivrate gering ist und das Verfahren wenig invasiv.

Abstract

Introduction: Aim of the palliative therapeutic procedure should be a fast, efficient and pain free treatment of the malignant pleural effusions.
Patients and method: Since 1995 the results of malignant pleural effusions treatment were analyzed retrospectively in 46 patients who underwent 51 video-assisted TTP. The most frequent origin of malignant pleural effusion was breast cancer, followed by bronchial carcinoma. Precondition for video-assisted TTP was the verification of a malignant pleural effusion by cytology.
Results: Following TTP one patient suffered from pneumonia, two recurrent diseases occurred. Four patients died due to their severe primary malignancy. Average hospitalization was 8 days (3-55).
Conclusion: Video-assisted TTP is the standard procedure in palliative treatment of malignant pleural effusion; the recurrence rate is low and the technique minimal invasive.

Schlüsselwörter

Maligner Pleuraerguss - Thorakoskopische Talkumpleurodese

Key words

Malignant pleural effusion - Thoracoscopic talcum pleurodesis

Literatur

  • 1 Aelony Y. Talc pleurodesis. Talc slurry versus talc poudrage.  Chest. 1995;  108 289
    PubMedGoogle Scholar
  • 2 Aelony Y. Cost-effective pleurodesis.  Chest. 1998;  113 1731-1732
    PubMedGoogle Scholar
  • 3 Aelony Y, King R, Boutin C. Thoracoscopic talc poudrage pleurodesis for chronic recurrent pleural effusions.  Ann Intern Med. 1991;  115 778-782
    CrossrefPubMedGoogle Scholar
  • 4 Boutin C, Viallat J R, Cargnino P, Farisse P. Thoracoscopy in malignant pleural effusions.  Am Rev Respir Dis. 1981;  124 588-592
    PubMedGoogle Scholar
  • 5 Chernow B, Sahn S A. Carcinomatous involvement of the pleura: an analysis of 96 patients.  Am J Med. 1977;  63 695-702
    CrossrefPubMedGoogle Scholar
  • 6 Fentiman I S, Rubens R D, Hayward J L. The pattern of metastatic disease in patients with pleural effusions secondary to breast cancer.  Br J Surg. 1982;  69 193-194
    PubMedGoogle Scholar
  • 7 Fentiman I S, Millis R, Sexton S, Hayward J L. Pleural effusion in breast cancer: a review of 105 cases.  Cancer. 1981;  47 2087-2092
    PubMedGoogle Scholar
  • 8 Furrer M, Inderbitzi R. Pleurodesis technique in malignant pleural effusion.  Schweiz Med Wochenschr. 1982;  122 181-188
    PubMedGoogle Scholar
  • 9 Glazer M, Berkman N, Lafair J S, Kramer M R. Successful talc slurry pleurodesis in patients with nonmalignant pleural effusion.  Chest. 2000;  117 1404-1409
    CrossrefPubMedGoogle Scholar
  • 10 Hartman D L, Gaither J M, Kesler K A, Mylet D M, Brown J W, Mathur P N. Comparison of insufflated talc under thoracoscopic guidance with standard tetracycline and bleomycin pleurodesis for control of malignant pleural effusions.  J Thorac Cardiovasc Surg. 1993;  105 743-747
    PubMedGoogle Scholar
  • 11 Hausheer F H, Yarbro J W. Diagnosis and treatment of malignant pleural effusion.  Semin Oncol. 1985;  12 54-75
    PubMedGoogle Scholar
  • 12 Inderbitzi R G, Grillet M P. Risk and hazards of video-thoracoscopic surgery: a collective review.  Eur J Cardiothorac Surg. 1996;  10 483-489
    CrossrefPubMedGoogle Scholar
  • 13 Keller S M. Current and future therapy for malignant pleural effusion.  Chest. 1993;  103 S63-S67
    PubMedGoogle Scholar
  • 14 Kennedy L, Vaughan L M, Steed L L, Sahn S A. Sterilization of talc for pleurodesis. Available techniques, efficacy, and cost analysis.  Chest. 1995;  107 1032-1034
    CrossrefPubMedGoogle Scholar
  • 15 Light R W, Vargas F S. Pleural sclerosis for the treatment of pneumothorax and pleural effusion.  Lung. 1997;  175 213-223
    PubMedGoogle Scholar
  • 16 Livingston R B, McCracken J D, Trauth C J, Chen T. Isolated pleural effusion in small cell lung carcinoma: favorable prognosis. A review of the Southwest Oncology Group experience.  Chest. 1982;  81 208-211
    PubMedGoogle Scholar
  • 17 Maiche A G. Management of peritoneal effusions with intracavitary mitoxantrone or bleomycin.  Anticancer Drugs. 1994;  5 305-308
    PubMedGoogle Scholar
  • 18 Marel M, Stastny B, Melinova L, Svandova E, Light R W. Diagnosis of pleural effusions. Experience with clinical studies, 1986 to 1990.  Chest. 1995;  107 1598-1603
    PubMedGoogle Scholar
  • 19 Martini N, Bains M S, Beattie E J. Indications for pleurectomy in malignant effusion.  Cancer. 1975;  35 734-738
    PubMedGoogle Scholar
  • 20 Milanez d C. Filho L O. de Campos W W. Sette H. Fernandez A. Filomeno L T. Jatene F B. Thoracoscopy and talc poudrage in the management of hepatic hydrothorax [see comments].  Chest. 2000;  118 13-17
    CrossrefPubMedGoogle Scholar
  • 21 Noppen M, Degreve J, Mignolet M, Vincken W. A prospective, randomised study comparing the efficacy of talc slurry and bleomycin in the treatment of malignant pleural effusions.  Acta Clin Belg. 1997;  52 258-262
    PubMedGoogle Scholar
  • 22 Rodriguez-Panadero F. Current trends in pleurodesis.  Curr Opin Pulm Med. 1997;  3 319-325
    PubMedGoogle Scholar
  • 23 Sartori S, Trevisani L, Nielsen I, Tassinari D, Abbasciano V. Intracavitary bleomycin vs interferon in the management of malignant pleural effusions.  Chest. 1998;  113 1145-1146
    CrossrefPubMedGoogle Scholar
  • 24 Schafers S J, Dresler C M. Update on talc, bleomycin, and the tetracyclines in the treatment of malignant pleural effusions.  Pharmacotherapy. 1995;  15 228-235
    PubMedGoogle Scholar
  • 25 Sorensen P G, Svendsen T L, Enk B. Treatment of malignant pleural effusion with drainage, with and without instillation of talc.  Eur J Respir Dis. 1984;  65 131-135
    PubMedGoogle Scholar
  • 26 Tschopp J M, Bolliger C T, Boutin C. Treatment of spontaneous pneumothorax: why not simple talc pleurodesis by medical thoracoscopy?.  Respiration. 2000;  67 108-111
    CrossrefPubMedGoogle Scholar
  • 27 Viallat J R, Boutin C. Malignant pleural effusions: recourse to early use of talc.  Rev.Med.Interne. 1998;  19 811-818
    PubMedGoogle Scholar
  • 28 Viallat J R, Rey F, Astoul P, Boutin C. Thoracoscopic talc poudrage pleurodesis for malignant effusions. A review of 360 cases.  Chest. 1996;  110 1387-1393
    CrossrefPubMedGoogle Scholar
  • 29 Viskum K, Lange P, Mortensen J. Long term sequelae after talc pleurodesis for spontaneous pneumothorax.  Pneumologie. 1989;  43 105-106
    PubMedGoogle Scholar
  • 30 Walker-Renard P B, Vaughan L M, Sahn S A. Chemical pleurodesis for malignant pleural effusions.  Ann Intern Med. 1994;  120 56-64
    CrossrefPubMedGoogle Scholar
  • 31 Walter M, Türler A, Schmitz-Rixen T. Die Talkum-Pleurodese bei rezidivierendem malignen Pleuraerguss - eine prospektive Beobachtungsstudie.  Zentralbl Chir. 1996;  121 216-222
    PubMedGoogle Scholar
  • 32 Weick J K, Kiely J M, Harrison E G. Carr D T. Scanlon P W. Pleural effusion in lymphoma.  Cancer. 1973;  31 848-853
    PubMedGoogle Scholar
  • 33 Weissberg D, Ben Zeev I. Talc pleurodesis. Experience with 360 patients.  J Thorac Cardiovasc Surg. 1993;  106 689-695
    PubMedGoogle Scholar
  • 34 Weissberg D, Kaufman M. The use of talc for pleurodesis in the treatment of resistant empyema.  Ann Thorac Surg. 1986;  41 143-145
    PubMedGoogle Scholar
  • 35 Yim A P, Izzat M B. Thoracoscopic talc poudrage for malignant effusions: should it be the procedure of choice?.  Chest. 1997;  112 1148
    PubMedGoogle Scholar

Dr. Gisela Brünagel

University of Pittsburgh

Department of Medicine

S851 Scaife Hall

3550 Terrace Street

Pittsburgh PA, 15261







Korrekturadresse
zurzeit - bis März 2003

Dr. med. Gisela Brünagel

Klinik und Poliklinik für Allgemein-, Viszeral-, Thorax- und Gefäßchirurgie

Rheinische Friedrich-Wilhelms-Universität Bonn

Sigmund-Freud-Str. 25

53105 Bonn

Phone: 02 28/2 87 51 09

      >